What the New Nonstimulant ADHD Medication Could Mean For Many Adults
2 min readMay 2, 2022
Just today, Supernus Pharmaceuticals announced that the FDA has expanded approval on their drug, Qelbree (Viloxazine XR), for adult usage. This is the first novel nonstimulant ADHD drug approved in 20 friggin years.
This is big news, and there are quite a few reasons why, but let’s go for the biggest reasons, shall we? We shall:
